Eastgate Biotech Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '17 Sep 30, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Revenue	0.14	-	0.13	-	-	-
Cost of Revenue	0.15	-	0.02	-	-	-
Gross Profit	-0.01	-	0.11	-	-	-
Selling, General & Admin	3.24	2.13	3.17	3.98	1.52	0.5
Research & Development	0.38	0.5	1.12	0.84	0.13	0.11
Operating Expenses	3.62	2.63	4.28	4.82	1.66	0.61
Operating Income	-3.63	-2.63	-4.17	-4.82	-1.66	-0.61
Interest Expense	-0.24	-0.16	-0.11	-0.09	-0.06	-0.02
EBT Excluding Unusual Items	-3.87	-2.79	-4.28	-4.91	-1.72	-0.62
Asset Writedown	-	-0.18	-	-	-	-
Pretax Income	-3.82	-2.98	-4.28	-4.91	-1.72	-0.62
Net Income	-3.82	-2.98	-4.28	-4.91	-1.72	-0.62
Net Income to Common	-3.82	-2.98	-4.28	-4.91	-1.72	-0.62
Shares Outstanding (Basic)	558	305	192	50	32	24
Shares Outstanding (Diluted)	558	305	192	50	32	24
Shares Change (YoY)	87.04%	59.16%	286.67%	56.60%	32.51%	105.29%
EPS (Basic)	-0.01	-0.01	-0.02	-0.10	-0.05	-0.03
EPS (Diluted)	-0.01	-0.01	-0.02	-0.10	-0.05	-0.03
Free Cash Flow	-1.81	-0.39	-0.57	-1.34	-0.43	-
Free Cash Flow Per Share	-0.00	-0.00	-0.00	-0.03	-0.01	-
Gross Margin	-8.46%	-	85.46%	-	-	-
Operating Margin	-2640.79%	-	-3159.54%	-	-	-
Profit Margin	-2774.35%	-	-3242.80%	-	-	-
Free Cash Flow Margin	-1314.10%	-	-430.56%	-	-	-
EBITDA	-3.55	-2.58	-4.13	-4.79	-1.64	-
D&A For EBITDA	0.09	0.05	0.04	0.03	0.01	-
EBIT	-3.63	-2.63	-4.17	-4.82	-1.66	-0.61

Updated Mar 4, 2019. Source: S&P Global Market Intelligence. Standard template. Financial Sources.